ACLX
Arcellx Inc

524
Mkt Cap
$6.69B
Volume
3.17M
52W High
$114.80
52W Low
$47.86
PE Ratio
-28.20
ACLX Fundamentals
Price
$114.77
Prev Close
$114.33
Open
$114.60
50D MA
$85.59
Beta
1.07
Avg. Volume
4.51M
EPS (Annual)
-$4.07
P/B
16.46
Rev/Employee
$106,631.58
$3,272.71
Loading...
Loading...
News
all
press releases
Arcellx (NASDAQ:ACLX) Sets New 52-Week High - Here's What Happened
Arcellx (NASDAQ:ACLX) Hits New 12-Month High - Here's What Happened...
MarketBeat·1h ago
News Placeholder
More News
News Placeholder
Are ACLX, MASI, FONR Obtaining Fair Deals for their Shareholders?
Are ACLX, MASI, FONR Obtaining Fair Deals for their Shareholders? Are ACLX, MASI, FONR Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, March 19, 2026 Insiders may stand to receive...
PR Newswire·1d ago
News Placeholder
JPMorgan Chase & Co. Decreases Holdings in Arcellx, Inc. $ACLX
JPMorgan Chase & Co. reduced its position in Arcellx, Inc. (NASDAQ:ACLX - Free Report) by 9.7% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 882,503 shares of the company's stock after selling 94,465 shar...
MarketBeat·2d ago
News Placeholder
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--TALK, UNF, ACLX, and FONR
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--TALK, UNF, ACLX, and FONR $HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--TALK, UNF, ACLX, and FONR...
PR Newswire·2d ago
News Placeholder
Top 2 Health Care Stocks That May Fall Off A Cliff This Month
Momentum warning for health care sector stocks: RSI indicator shows overbought assets. Arcellx (ACLX) and Atea Pharma (AVIR) among top-ranked.read more...
Benzinga·2d ago
News Placeholder
Gilead Sciences at Barclays: CFO touts YEZTUGO launch, Arcellx deal and long cycle growth
Gilead Sciences (NASDAQ:GILD) Chief Financial Officer Andrew Dickinson told investors at the Barclays conference that the company is entering what he described as the beginning of a long cycle...
MarketBeat·4d ago
News Placeholder
This $64 Million Biotech Exit Seemingly Missed a 77% One-Day Surge on Gilead Takeover Deal
Key PointsCormorant Asset Management sold 775,000 Arcellx shares in the fourth quarter...
Nasdaq News: Markets·4d ago
News Placeholder
Are MASI, ACLX, GLDD Obtaining Fair Deals for their Shareholders?
Are MASI, ACLX, GLDD Obtaining Fair Deals for their Shareholders? Are MASI, ACLX, GLDD Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, March 16, 2026 Insiders may stand to receive...
PR Newswire·4d ago
News Placeholder
Arcellx, Inc. $ACLX Position Lifted by HighVista Strategies LLC
HighVista Strategies LLC lifted its stake in Arcellx, Inc. (NASDAQ:ACLX - Free Report) by 169.3% in the 3rd quarter, according to the company in its most recent filing with the Securities and...
MarketBeat·4d ago
News Placeholder
Bamco Inc. NY Has $45.17 Million Stake in Arcellx, Inc. $ACLX
Bamco Inc. NY lifted its holdings in Arcellx, Inc. (NASDAQ:ACLX - Free Report) by 6.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC...
MarketBeat·5d ago
<
1
2
...
>

Latest ACLX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.